Insider trading

Period: 120 months Stock: RGNX Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Jul 2026
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$29.48K 2,161 at 13.64
1.0%
Planned (10b5-1)
1 Jul 2026
PAKOLA STEVE Chief Medical Officer
Sold at will
$472.28K 36,725 at 12.86
14.7%
Not planned
29 Jun 2026
PAKOLA STEVE Chief Medical Officer
Sold at will
$216.47K 19,608 at 11.04
8.4%
Not planned
11 May 2026
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$168.71K 15,309 at 11.02
6.2%
Planned (10b5-1)
10 Mar 2026
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$53.03K 5,124 at 10.35
2.0%
Planned (10b5-1)
5 Mar 2024
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$365.22K 12,878 at 28.36
10.7%
Planned (10b5-1)
3 Jan 2024
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$299.79K 17,237 at 17.39
13.9%
Planned (10b5-1)
3 Jan 2023
PAKOLA STEVE Chief Medical Officer
Sold, plan not stated
$69.56K 3,138 at 22.17
20.5%
3 Jan 2022
PAKOLA STEVE Chief Medical Officer
Sold, plan not stated
$53.93K 1,598 at 33.75
16.2%
12 Feb 2021
Christmas Patrick J. Chief Legal Officer
Sold, plan not stated
$230.73K 4,701 at 49.08
22.3%
8 Feb 2021
Christmas Patrick J. Chief Legal Officer
Sold, plan not stated
$63.84K 1,300 at 49.11
7.4%
2 Feb 2021
Christmas Patrick J. Chief Legal Officer
Sold, plan not stated 2×
$447.88K 10,000 at 44.79
37.9%
14 Jan 2021
Simpson Curran Chief Oper. & Tech. Officer
Sold, plan not stated
$580.72K 11,612 at 50.01
39.6%
12 Jan 2021
Simpson Curran Chief Oper. & Tech. Officer
Sold, plan not stated
$85.05K 1,700 at 50.03
8.7%
12 Jan 2021
Christmas Patrick J. Chief Legal Officer
Sold, plan not stated
$67.73K 1,378 at 49.15
7.8%
11 Jan 2021
Christmas Patrick J. Chief Legal Officer
Sold, plan not stated
$496.79K 10,122 at 49.08
38.2%
8 Jan 2021
Christmas Patrick J. Chief Legal Officer
Sold, plan not stated 3×
$470.57K 10,000 at 47.06
37.9%
7 Jan 2021
Simpson Curran Chief Oper. & Tech. Officer
Sold, plan not stated
$259.30K 5,185 at 50.01
22.6%
11 Feb 2020
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated 2×
$634.41K 12,564 at 50.49
76.1%
Sold half or more
10 Feb 2020
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$2.23M 44,429 at 50.22
81.8%
Sold half or more
5 Feb 2020
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$281.85K 5,637 at 50.00
19.9%
17 Jan 2020
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$296.10K 5,922 at 50.00
20.4%
9 Dec 2019
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated 2×
$680.25K 15,552 at 43.74
39.4%
12 Sep 2019
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$230.41K 5,486 at 42.00
68.1%
Sold half or more
19 Jul 2019
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$245.15K 4,900 at 50.03
61.6%
Sold half or more
18 Jul 2019
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$5.00K 100 at 50.00
3.2%
18 Jun 2019
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 3×
$264.96K 5,000 at 52.99
62.5%
Sold half or more
28 May 2019
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$900.00K 18,000 at 50.00
31.3%
18 Apr 2019
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 4×
$266.16K 5,000 at 53.23
62.5%
Sold half or more
15 Apr 2019
Danos Olivier Chief Scientific Officer
Sold, plan not stated 2×
$105.32K 2,000 at 52.66
23.5%
25 Feb 2019
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$286.47K 5,300 at 54.05
11.8%
5 Feb 2019
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$2.20M 43,832 at 50.08
52.6%
Sold half or more
18 Dec 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 3×
$237.70K 5,000 at 47.54
65.2%
Sold half or more
3 Dec 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 3×
$1.23M 20,414 at 60.13
100%
Sold half or more
19 Nov 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 6×
$1.22M 20,414 at 59.53
100%
Sold half or more
16 Nov 2018
Simpson Curran SVP, Technical Operations
Sold, plan not stated 4×
$2.10M 32,882 at 63.76
45.4%
7 Nov 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$1.08M 15,000 at 72.06
84.9%
Sold half or more
5 Nov 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 5×
$1.39M 20,414 at 68.28
100%
Sold half or more
29 Oct 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 6×
$1.27M 20,414 at 62.37
100%
Sold half or more
18 Oct 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 3×
$308.89K 5,000 at 61.78
22.1%
16 Oct 2018
Simpson Curran SVP, Technical Operations
Sold, plan not stated 3×
$3.79M 62,309 at 60.85
61.2%
Sold half or more
16 Oct 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated
$637.13K 10,414 at 61.18
100%
Sold half or more
15 Oct 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 3×
$593.41K 10,000 at 59.34
100%
Sold half or more
8 Oct 2018
Danos Olivier Chief Scientific Officer
Sold, plan not stated 4×
$1.28M 20,000 at 63.80
100%
Sold half or more
20 Aug 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 2×
$329.81K 5,000 at 65.96
22.1%
18 Jun 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 2×
$283.89K 5,000 at 56.78
23.7%
9 May 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated 2×
$650.00K 15,000 at 43.33
92.9%
Sold half or more
11 Apr 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$390.00K 10,000 at 39.00
89.8%
Sold half or more
9 Apr 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$340.00K 10,000 at 34.00
89.8%
Sold half or more
13 Mar 2018
Simpson Curran SVP, Technical Operations
Sold, plan not stated
$825.00K 25,000 at 33.00
38.8%
Showing 1–50 of 60. Page 1 of 2 Older →